News

On 26th June, Cristina Codina Blas has presented and defended her Final Degree Project of the academic program Degree in Biotechnology at IQS School of Engineering (Barcelona, Spain). For three months, she has worked in Vascular Engineering and Applied Biomedicine (GEVAB) research group of Assist. Prof. Jordi Martorell. Co-supervised by postdoctoral researcher Sara Fuentelsaz, Cristina’s work has…

IMMUTOL coordinator, Dr. Silvia Gregori gave a talk with the title ‘IL-10 Producing Tolerogenic Dendritic Cells Modulate B Cell Responses in vitro and in vivo’ at the Federation of Clinical Immunology Societies (FOCIS) 2024 Annual Meeting held between June 18th -21th of June, San Francisco, CA, USA. Using the link to the event ( https://www.focisnet.org/meetings/focis-2024/ ) you can find further information about…

Sara Fuentelsaz Romero, member of the IMMUTOL project from the IQS team, attended the Barcelona Blood-Brain Barrier (B4) Symposium. The event was organised by the Institute for Bioengineering of Catalonia (IBEC) and took place on 21 and 22 May.   Read more: IBEC hosts first Barcelona Blood-Brain Barrier Symposium – Institute for Bioengineering of Catalonia…

The IMMUTOL consortium met for the 1st Annual Meeting in Barcelona on the 6th and 7th of June 2024, hosted by the team of Assist. Prof. Jordi Martorell López at the Department of Chemical Engineering and Materials Science at the Institut Químic de Sarrià (IQS), Barcelona Spain. The 2-day event was a great occasion to…

Montse de Castellarnau Serra, PhD recently joined Immutol team from ASPHALION! Welcome!

In 26th February 2024 UHREG’s Doctoral Candidate Giulia Preverin participated in a career information day at one of Regensburg’s high schools, the Albertus-Magnus-Gymnasium. The aim of the event was to talk to 9th grade students about possible career choices. Speakers from various backgrounds and with a wide range of careers were invited. Each speaker was…

SAVE THE DATE! IMMUTOL 1st Annual Meeting will be held on 6th and 7th June 2024 in Barcelona at IQS facilities.

Press Release: English https://techtransfer.iqs.edu/en/news/new-effective-therapies-for-multiple-sclerosis/ Spanish https://techtransfer.iqs.edu/actualidad/nuevas-terapias-efectivas-para-la-esclerosis-multiple/ Catalan https://techtransfer.iqs.edu/ca/actualitat/noves-terapies-efectives-per-lesclerosi-multiple/

The IMMUTOL Consortium, led by Silvia Gregori (San Raffaele Telethon Institute for Gene Therapy– SR-TIGET) successfully kicked-off the project at a hybrid event, held at the Fondazione Telethon, Milano (Italy), between 24th and 25th of May. Thanks to EU Horizon Europe (Grant Agreement Nr.: 101080562) for supporting fast-tracking the development and validation of an Advanced…